Literature DB >> 14766226

Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing.

Naoko Takahashi1, Shinya Kobayashi, Xu Jiang, Koji Kitagori, Kenichi Imai, Yurina Hibi, Takashi Okamoto.   

Abstract

The p53 binding protein 2 (53BP2) has been initially identified as an interacting protein to p53 and subsequent studies have shown that it also interacts with Bcl-2 and NF-kappaB p65 subunit. We have previously found that the TP53BP2 gene encoding 53BP2 protein is a single copy gene and has been mapped to the long arm of chromosome 1 at q42.1. The subsequent studies revealed that TP53BP2 encodes two proteins, 53BP2 and ASPP2, of 1005 and 1128 amino acids, respectively. ASPP2 contains additional 123 amino acids to the N-terminus of 53BP2. In this study, we have examined the genomic organization of TP53BP2 transcripts and found that it encodes two mRNA species, either with (53BP2) or without exon 3 (ASPP2), by alternative splicing in various cell lines and tissues. Thus, we propose to call these proteins as 53BP2S (short) and 53BP2L (long), respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766226     DOI: 10.1016/j.bbrc.2004.01.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Authors:  Zhiping Wang; Yuangang Liu; Maho Takahashi; Kathryn Van Hook; Kerstin M Kampa-Schittenhelm; Brett C Sheppard; Rosalie C Sears; Philip J S Stork; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

2.  ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.

Authors:  Kathryn Van Hook; Zhiping Wang; Dexi Chen; Casey Nold; Zhiyi Zhu; Pavana Anur; Hun-Joo Lee; Zhiyong Yu; Brett Sheppard; Mu-Shui Dai; Rosalie Sears; Paul Spellman; Charles D Lopez
Journal:  Biochem Biophys Res Commun       Date:  2016-12-08       Impact factor: 3.575

3.  Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.

Authors:  Kerstin M Kampa; Jared D Acoba; Dexi Chen; Joel Gay; Hunjoo Lee; Kelly Beemer; Emerson Padiernos; Nataya Boonmark; Zhiyi Zhu; Alice C Fan; Alexis S Bailey; William H Fleming; Christopher Corless; Dean W Felsher; Louie Naumovski; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

4.  Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy.

Authors:  Jing Ji; Xiaoshuang Zhou; Ping Xu; Yafeng Li; Honglin Shi; Dexi Chen; Rongshan Li; Hongbo Shi
Journal:  J Cell Mol Med       Date:  2019-01-23       Impact factor: 5.310

5.  Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2.

Authors:  Tianqi Wu; Hongming Song; Dan Xie; Kaiyao Hua; Jiashu Hu; Yijun Deng; Changle Ji; Lin Fang
Journal:  Biomed Res Int       Date:  2020-04-29       Impact factor: 3.411

6.  Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells.

Authors:  Michaël Imbeault; Michel Ouellet; Michel J Tremblay
Journal:  Retrovirology       Date:  2009-01-15       Impact factor: 4.602

Review 7.  [P53 family proteins provide new insights into lung carcinogenesis and clinical treatment].

Authors:  Wenyan Huang; Kaishan Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.